
Atrium Therapeutics, Inc.
USD13.80
+0.15 (+1.10%)
CEO
Kathleen Gallagher
IPO Date
2026-02-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.67
Prev. Close
$13.65
Day Low
$13.57
Day High
$13.80
52W Low
$11.40
52W High
$16.77
Market Cap
$0.24B
Volume
0.09M
| 28 Oct 2025 |
| RBC Capital |
| Outperform |
| Sector Perform |
| downgrade |
| 27 Oct 2025 | Citigroup | Buy | Neutral | downgrade |
| 27 Oct 2025 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 27 Oct 2025 | Raymond James | Strong Buy | Market Perform | downgrade |
| 27 Oct 2025 | Bernstein | Outperform | Market Perform | downgrade |
| 27 Oct 2025 | Needham | Buy | Hold | downgrade |
| 27 Oct 2025 | Leerink Partners | Outperform | Market Perform | downgrade |